SOP10

We cordially invite you to join the PEDIA (Prioritization of Exome Data by Image Analysis) study:

Join the Study

Scientific challenge: A probabilistic interpretation of big data consisting of phenotype and genotype information.

Aim of study: Assess combination of gestalt-match, feature-match, and variant-scores for disease-gene inference.

Prerequisites: Submit frontal facial photos of syndromic patients with a molecularly confirmed diagnosis and VCF or genomic information to Face2Gene, and annotate relevant clinical features.

Benefits: Filtered VCF files, disease-gene prediction, co-authorship in publication.

How to: Register to Face2Gene and contact Dr. Peter Krawitz at pedia@charite.de

Line blue

 

 

sienagoettingen     harbor2 spzentrumbchkimginnsbruckchuamiens  halle  uke_logomedizin_uniklinikum-logoljubljana800px-leeds_university_logo-svg

 

Standard Operating Procedure for PEDIA Study

View tutorial in this link.

1. Login to https://legacy.face2gene.com  (the new version of Face2Gene at www.app.face2gene.com does not support yet the PEDIA study)

2. Add new case and upload photo

SOP1

3. Deep phenotyping: check suggested features that apply and complete list for feature match

SOP2

 

4. a)  Under “Genomic Data”, add the pathogenic mutationSOP3

AND IF AVAILABLE

b) Under “Photos and Files”, add VCF file (including pathogenic mutation)
SOP5

 

5. Select correct diagnosis and mark as molecular

SOP11

6. Submit to study by adding #PEDIA to the Case Name, on the top of your screen. The “#PEDIA” code can be in addition to a case name you added. For example:

SOP8

 
 

The Face2Gene User Community

  • Using Face2Gene to reference all my department’s cases, share information with my colleagues and quickly look up relevant information in the London Medical Databases Online saves me hours of work every week and allows me to focus on my patients.

    Dr. Ibrahim Akalin

    Assoc. Prof. Ibrahim Akalin, MD, Medical Genetecist from the Istanbul Medeniyet University, Istanbul, Turkey

  • FDNA’s game-changing technology introduces an objective computer-aided dimension to the “art of dysmorphology”, transforming the analysis into an evidence-based science.

    Dr. Michael R. Hayden

    Chairman of FDNA’s Scientific Advisory Board & Steering Committee and Editor in Chief of Clinical Genetics

  • FDNA is developing technology that has the potential to help so many physicians and families by bringing them closer to a diagnosis- there are literally millions of individuals with unusual features around the world that lack a diagnosis and therefore lack information on natural history, recurrence risk and prevention of known complications.

    Dr. Judith G. Hall

    Professor Emerita of Pediatrics & Medical Genetics UBC & Children's and Women's Health Centre of BC

  • FDNA has been “right on the money”, providing me with relevant, accurate and insightful information for differential diagnoses.

    Dr. Cynthia J.R. Curry

    Professor of Pediatrics UCSF, Adjunct Professor of Pediatrics Stanford

  • I am excited to be a part of the FDNA community, promoting broad information sharing with my peers to amplify the scientific and clinical value of our community’s accumulated knowledge for the purpose of efficiently diagnosing individuals with rare genetic disorders.

    Dr. Karen W. Gripp

    Chief, Division of Medical Genetics A.I. duPont Hospital for Children

  • FDNA's idea of incorporating several dysmorphology resources (OMIM, GeneReviews), supported by their visual analytic technology, will be able to improve researching of genetic syndromes - all within a single mobile app.

    Dr. Chad Haldeman-Englert

    Assistant Professor Pediatrics at Wake Forest Baptist Medical Center

  • Given the advancement of visual analytical technology, it’s about time Dysmorphology is supported with computational capabilities and moving this to mobile support, is simply the next logical step.

    Dr. Chanika Phornphutkul

    Associate Professor of Pediatrics Director, Division of Human Genetics Department of Pediatrics Warren Alpert Medical School of Brown University

  • Having an archive of cases easily accessible from my mobile device anytime and anywhere is a long-time unmet need.

    Dr. Lynne Bird

    Rady Children's Specialists of San Diego

  • FDNA's solution is a huge leap forward for dysmorphology. It saves me significant time when I’m evaluating patients in my clinic and provides me with insightful tools that help me generate a differential diagnosis.

    Dr. David A. Chitayat

    Head of the Prenatal Diagnosis and Medical Genetics Program at Mount Sinai Hospital, Toronto

  • Shortly after learning about Face2Gene, I’ve started to incorporate this amazing tool into my workflow. Soon enough, Face2Gene’s analysis flushed out references that I would not have considered for several of my patients, which turned out to be their correct diagnosis

    Dr. Zvi U. Borochowitz

    Chairman (Retired) of The Simon Winter Institute for Human Genetics at Bnai-Zion Medical Center, Technion-Rappaport Faculty of Medicine

  • The Unknown Forum from Face2Gene is a great community platform for exchanging opinions regarding undiagnosed cases. It is straightforward to use and safe for exchange of medical data, thanks to the efforts of its developers and to the involvement of geneticists worldwide.

    Dr. Oana Moldovan

    Clinical Geneticist at the Hospital Santa Maria, CHLN, Lisbon, Portugal